Richard Kellermayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Richard Kellermayer has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
György Kosztolányi
MTA‐PTE Clinical Genetics Research Group, University of Pécs, Pécs, Hungary
5 shared publicationsMárta Czakó
Department of Medical Genetics and Child Development, University of Pécs, Pécs, Hungary
4 shared publicationsReka Szigeti
4 shared publicationsRéka Szigeti
University of Pecs
4 shared publicationsAlexandra Tészás
University of Pecs
3 shared publicationsDorottya Nagy-Szakal
3 shared publications
Latest Publications
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1699 Prenatal Methyl-Donor Micronutrient Supplementation Induces an Acute Colitis Prone Microbiome in Young Adult Mice
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1699 Prenatal Methyl-Donor Micronutrient Supplementation Induces an Acute Colitis Prone Microbiome in Young Adult Mice
- Open Access
- 1 December 2011
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (Suppl_2) , S9
SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice
SMAD4 is a common mediator (co-SMAD) of the TGF-Beta signaling pathway. One of the members of this pathway, TGF-beta 1, has an important role in controlling gut inflammation in relation to the continuous stimulation of the normal intestinal microbiota. SMAD4 haploinsufficiency in humans has been linked to juvenile polyposis with hereditary hemorrhagic telangiectasia syndrome (JP/HHT; OMIM#17505). Patients with JP/HHT usually have numerous juvenile polyps in the gastrointestinal tract and arterio-venous malformations throughout the body. Hematochezia and colonic mucosal inflammation suggestive of inflammatory bowel diseases have been reported in JP/HHT. Stimulated by recent experience with two affected patients, we explored the potential role of Smad4 haploinsufficiency in colonic inflammation in a murine model. Smad4+/− mice were maintained on a mixed C57/129SvEv background. Smad4 haploinsufficient animals and littermate controls were generated by crossing Smad4+/− to C57/129SvEv F1 hybrid mice. Chronic colitis was induced with repeated administration of dextran sulfate sodium (DSS) in drinking water. The colonic mucosal (from sheared colonic mucosa) microbiome was interrogated by massive parallel pyrosequencing of the bacterial 16S rRNA gene. A subset of the non-inbred Smad4+/− mice was sensitive to DSS colitis independently from litter status or the colonic mucosal microbiome. Smad4 haploinsufficiency can associate with increased susceptibility to large bowel inflammation in humans and mice with variable penetrance.
- 1 December 2011
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (Suppl_2) , S9
Open AccessSMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice
SMAD4 is a common mediator (co-SMAD) of the TGF-Beta signaling pathway. One of the members of this pathway, TGF-beta 1, has an important role in controlling gut inflammation in relation to the continuous stimulation of the normal intestinal microbiota. SMAD4 haploinsufficiency in humans has been linked to juvenile polyposis with hereditary hemorrhagic telangiectasia syndrome (JP/HHT; OMIM#17505). Patients with JP/HHT usually have numerous juvenile polyps in the gastrointestinal tract and arterio-venous malformations throughout the body. Hematochezia and colonic mucosal inflammation suggestive of inflammatory bowel diseases have been reported in JP/HHT. Stimulated by recent experience with two affected patients, we explored the potential role of Smad4 haploinsufficiency in colonic inflammation in a murine model. Smad4+/− mice were maintained on a mixed C57/129SvEv background. Smad4 haploinsufficient animals and littermate controls were generated by crossing Smad4+/− to C57/129SvEv F1 hybrid mice. Chronic colitis was induced with repeated administration of dextran sulfate sodium (DSS) in drinking water. The colonic mucosal (from sheared colonic mucosa) microbiome was interrogated by massive parallel pyrosequencing of the bacterial 16S rRNA gene. A subset of the non-inbred Smad4+/− mice was sensitive to DSS colitis independently from litter status or the colonic mucosal microbiome. Smad4 haploinsufficiency can associate with increased susceptibility to large bowel inflammation in humans and mice with variable penetrance.
- Open Access
- 1 December 2011
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (Suppl_2) , S65
Genome wide peripheral blood leukocyte DNA methylation microarrays failed to identify associations with Inflammatory Bowel Diseases
Crohn's disease (CD) and ulcerative colitis (UC) are common forms of inflammatory bowel diseases (IBD). Monozygotic (MZ) twin discordance rates and other epidemiologic data implicate that environmental and potential epigenetic factors may play a pathogenic role in IBD. DNA methylation (the methylation of cytosines within CpG dinucleotides) is an epigenetic modification, which can respond to environmental influences. Methylation changes in peripheral blood leukocyte (PBL) DNA have been shown to associate with autoimmune diseases, such as systemic lupus erythematosus. We investigated whether similar epigenetic modification might be connected with IBD. Two different microarray based methods for genome wide DNA methylation analysis were employed. First, DNA isolated from MZ twins concordant (CD: 4; UC: 3) and discordant (CD: 4; UC: 7) for IBD was interrogated by a custom made methylation specific amplification microarray (MSAM). Second, Illumina Infinium HumanMethylation450 BeadChip arrays were used on 48 samples of PBL DNA from discordant MZ twins (CD:3; UC:3) and untreated pediatric cases of IBD (CD:14; UC:8), as well as controls (n=14). The microarrays were validated with bisulfite pyrosequencing. Neither the MSAM nor the Methylation BeadChip approach demonstrated significant associations between DNA methylation and IBD. Microarray interrogation of IBD dependent DNA methylation from PBLs is less likely to yield significant results. More detailed and/or intestinal tissue specific approaches may be useful for the elucidation of connections between the DNA methylome and IBD.
- 1 December 2011
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (Suppl_2) , S65
Open AccessGenome wide peripheral blood leukocyte DNA methylation microarrays failed to identify associations with Inflammatory Bowel Diseases
Crohn's disease (CD) and ulcerative colitis (UC) are common forms of inflammatory bowel diseases (IBD). Monozygotic (MZ) twin discordance rates and other epidemiologic data implicate that environmental and potential epigenetic factors may play a pathogenic role in IBD. DNA methylation (the methylation of cytosines within CpG dinucleotides) is an epigenetic modification, which can respond to environmental influences. Methylation changes in peripheral blood leukocyte (PBL) DNA have been shown to associate with autoimmune diseases, such as systemic lupus erythematosus. We investigated whether similar epigenetic modification might be connected with IBD. Two different microarray based methods for genome wide DNA methylation analysis were employed. First, DNA isolated from MZ twins concordant (CD: 4; UC: 3) and discordant (CD: 4; UC: 7) for IBD was interrogated by a custom made methylation specific amplification microarray (MSAM). Second, Illumina Infinium HumanMethylation450 BeadChip arrays were used on 48 samples of PBL DNA from discordant MZ twins (CD:3; UC:3) and untreated pediatric cases of IBD (CD:14; UC:8), as well as controls (n=14). The microarrays were validated with bisulfite pyrosequencing. Neither the MSAM nor the Methylation BeadChip approach demonstrated significant associations between DNA methylation and IBD. Microarray interrogation of IBD dependent DNA methylation from PBLs is less likely to yield significant results. More detailed and/or intestinal tissue specific approaches may be useful for the elucidation of connections between the DNA methylome and IBD.
- 1 January 2011
- Vol. 41 (3) , 288-9
Peri-appendiceal inflammation in an 8-year-old child with chronic ulcerative colitis.
The peri-appendiceal red patch (PARP) or appendiceal orifice inflammation (AOI) is a known complication of non-pancolonic ulcerative colitis (UC), but it is not well documented in the pediatric pathology and gastroenterology literature. Here we describe the youngest patient with this manifestation to date and provide a brief review on PARP associated UC.
- 1 January 2011
- Vol. 41 (3) , 288-9
Peri-appendiceal inflammation in an 8-year-old child with chronic ulcerative colitis.
The peri-appendiceal red patch (PARP) or appendiceal orifice inflammation (AOI) is a known complication of non-pancolonic ulcerative colitis (UC), but it is not well documented in the pediatric pathology and gastroenterology literature. Here we describe the youngest patient with this manifestation to date and provide a brief review on PARP associated UC.
- 1 December 2006
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 12 (4) , 234-236
Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat
Autosomal dominant mutations in the genes encoding the calcium ATPases SERCA2 and PMR1/SPCA1 cause the genodermatoses Darier disease (DD) and Hailey-Hailey disease (HHD), respectively. Recent observations indicated that the level of the pathogenic proteins greatly decreases in the affected areas of the epidermis in these disorders. Here we addressed how lithium, a recognized exacerbating factor in Darier disease, affects the epidermal expression of SERCA2 and PMR1/SPCA1 in the rat as a model. Standard histologic and immunohistochemical methods were utilized in 3 lithium-treated and 3 control animals. A significant suppression of epidermal SERCA2 and PMR1 levels were observed as a result of lithium therapy in addition to marked qualitative and quantitative changes in the stratum corneum and the granular layer of the epidermis in the treated animals. Our findings suggest that exacerbating factors in calcium ATPase disorders of the skin suppress epidermal SERCA2 and PMR1 levels, further decreasing the already haploinsufficient protein expression to a potentially critical level in Darier disease and Hailey-Hailey disease, respectively. Lithium therapy should specifically be avoided not only in Darier disease, but Hailey-Hailey disease as well.
- 1 December 2006
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 12 (4) , 234-236
Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat
Autosomal dominant mutations in the genes encoding the calcium ATPases SERCA2 and PMR1/SPCA1 cause the genodermatoses Darier disease (DD) and Hailey-Hailey disease (HHD), respectively. Recent observations indicated that the level of the pathogenic proteins greatly decreases in the affected areas of the epidermis in these disorders. Here we addressed how lithium, a recognized exacerbating factor in Darier disease, affects the epidermal expression of SERCA2 and PMR1/SPCA1 in the rat as a model. Standard histologic and immunohistochemical methods were utilized in 3 lithium-treated and 3 control animals. A significant suppression of epidermal SERCA2 and PMR1 levels were observed as a result of lithium therapy in addition to marked qualitative and quantitative changes in the stratum corneum and the granular layer of the epidermis in the treated animals. Our findings suggest that exacerbating factors in calcium ATPase disorders of the skin suppress epidermal SERCA2 and PMR1 levels, further decreasing the already haploinsufficient protein expression to a potentially critical level in Darier disease and Hailey-Hailey disease, respectively. Lithium therapy should specifically be avoided not only in Darier disease, but Hailey-Hailey disease as well.
- 27 November 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 412-413
Premenstrual exacerbation in calcium ATPase disorders of the skin
- 27 November 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 412-413
Premenstrual exacerbation in calcium ATPase disorders of the skin
- 1 November 2006
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 49 (6) , 445-450
Translational readthrough induction of pathogenic nonsense mutations
- 1 November 2006
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 49 (6) , 445-450
Translational readthrough induction of pathogenic nonsense mutations
- 1 November 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (11) , 2370-2376
Autosomal-Dominant Calcium ATPase Disorders
- 1 November 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (11) , 2370-2376
Autosomal-Dominant Calcium ATPase Disorders
- 20 October 2006
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 140A (24) , 2816-2818
High incidence of short rib‐polydactyly syndrome type IV in a Hungarian Roma subpopulation
- 20 October 2006
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 140A (24) , 2816-2818
High incidence of short rib‐polydactyly syndrome type IV in a Hungarian Roma subpopulation
- 1 October 2006
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 124 (10) , 1490
Presenile Cataract: Consider Cholestanol
- 1 October 2006
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 124 (10) , 1490
Presenile Cataract: Consider Cholestanol